<DOC>
	<DOCNO>NCT00067041</DOCNO>
	<brief_summary>Approximately 30 patient enrol 12-week study design assess effect continuous subcutaneous Remodulin therapy outcome infrainguinal bypass graft patient critical limb ischemia ( CLI ) . Portions study conduct hospital out-patient basis . The study conduct multiple center .</brief_summary>
	<brief_title>Effects Remodulin Patients With Critical Limb Ischemia Following Vein Bypass Graft</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Treprostinil</mesh_term>
	<criteria>Patients critical limb ischemia appropriate reference lowerlimb ischemic wound due document peripheral arterial disease autogenous vein infrainguinal bypass graft perform immediately prior study initiation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>Autogenous Bypass Graft</keyword>
	<keyword>CLI</keyword>
</DOC>